Emerging Public Health Law and Policy Issues Concerning State Medical Cannabis Programs.

J Law Med Ethics

William Tilburg, J.D., M.P.H., is Director, Policy and Government Relations for the Maryland Medical Cannabis Commission. James G. Hodge, Jr., J.D., LL.M., is Professor of Public Health Law and Ethics; Director, Center for Public Health Law and Policy, Sandra Day O'Connor College of Law, Arizona State University; and Director, Western Region Office, Network for Public Health Law. Camille Gourdet, J.D., M.A., is Research Public Health Analyst, RTI International.

Published: June 2019

Thirty-four states, the District of Columbia, and Puerto Rico have legalized medical cannabis. While no two state medical cannabis programs are alike, public health concerns related to advertising, packaging and labeling, pesticide use, scientific research, and the role of medical cannabis in the opioid crisis are emerging across the country. This article examines these issues, the policy approaches states are adopting to protect patients and the public, and an assessment of the underlying federal legal landscape.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073110519857331DOI Listing

Publication Analysis

Top Keywords

medical cannabis
16
public health
8
state medical
8
cannabis programs
8
emerging public
4
health law
4
law policy
4
policy issues
4
issues concerning
4
concerning state
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!